We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Transmedics Group Inc (TMDX) NPV

Sell:$81.80 Buy:$83.99 Change: $3.50 (4.01%)
NASDAQ:2.05%
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:$81.80
Buy:$83.99
Change: $3.50 (4.01%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:$81.80
Buy:$83.99
Change: $3.50 (4.01%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Contact details

Address:
200 Minuteman Road
ANDOVER
01810
United States
Telephone:
+1 (978) 5520900
Website:
https://www.transmedics.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
TMDX
ISIN:
US89377M1099
Market cap:
$2.89 billion
Shares in issue:
32.85 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Waleed Hassanein
    President, Chief Executive Officer, Director
  • Stephen Gordon
    Chief Financial Officer, Treasurer, Secretary
  • Anil Ranganath
    Senior Vice President, General Counsel, Company Secretary
  • Nick Corcoran
    Senior Vice President - Supply Chain and Operations
  • Laura Damme
    Vice President - Clinical Affairs
  • Miriam Provost
    Vice President - Global Regulatory Affairs
  • Tamer Khayal
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.